OXIDIEN PHARMACEUTICALS
DEAD

Serial Number

98212166

Owner

OXIDIEN PHARMACEUTICALS, LLC

Attorney

Amber N. Davis

Filing Date

Oct 6, 2023

Add to watchlist:

No watchlists yet
View on USPTO

OXIDIEN PHARMACEUTICALS Trademark

Serial Number: 98212166

OXIDIEN PHARMACEUTICALS is a trademark filed by OXIDIEN PHARMACEUTICALS, LLC on October 6, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

OXIDIEN PHARMACEUTICALS, LLC (3 trademarks)

747 SW 2nd Avenue, Suite 240
GAINESVILLE, FL 32601

Entity Type: 16

Trademark Details

Filing Date

October 6, 2023

Registration Date

Not Registered

Published for Opposition

July 2, 2024

Goods & Services

Pharmaceutical preparations, substances and products for use in nephrology and urology, namely, for the treatment and prevention of kidney-related disease, namely, kidney stones, hyperoxaluria, hyperoxalemia, and chronic kidney disease

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; scientific and technological services, namely, research and development of new products for others, and scientific research in the field of pharmaceutics, and scientific laboratory services; medical and pharmacological research services, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations, and drugs; natural science services, namely, biological research, and chemical analysis of industrial and clinical fluids; medical and scientific research in the field of pharmaceutical preparations, and drugs; clinical testing, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations, and drugs; product development of probes, reagents and bioassays for industrial and scientific purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 31, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 31, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 27, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 29, 2024 CNEA
ASSIGNED TO EXAMINER
May 28, 2024 DOCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 10, 2024 ASCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 14, 2023 NWOS
NEW APPLICATION ENTERED
Oct 10, 2023 NWAP